Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines.
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2015
At a glance
- Drugs Daunorubicin liposomal (Primary)
- Indications Kaposi's sarcoma
- Focus Pharmacodynamics; Pharmacogenomic
- 01 Dec 2011 Actual patient number is 14 according to ClinicalTrials.gov.
- 01 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 01 Dec 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.